Evaluation of interleukin-8 in hepatitis C virus infection: Relation to combined peg-interferon ribavirin response and genotype 4

Immunological Investigations

Volumn 40, Issue 1, 2011, Pages 29-38

  Maysaa El Sayed, Zaki ^a   Mansour, F A ^b,c   Ghal, M F ^c   Abou Zahra, S B ^c  

^a MANSOURA UNIVERSITY   (Egypt)

^b Mansoura University   (Egypt)

^c Zagazig University   (Egypt)

Author keywords

Combined peg interferon Ribavirin; HCV; IL 8

Indexed keywords

HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 8; PEGINTERFERON ALPHA2A; RIBAVIRIN; UNCLASSIFIED DRUG; VIRACURE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TREATMENT RESPONSE; VIREMIA; VIRUS LOAD;

ADULT; ANTIBODIES, VIRAL; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNOGLOBULIN G; INTERFERON-ALPHA; INTERLEUKIN-8; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RIBAVIRIN; TREATMENT OUTCOME;

EID: 78650065755     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.3109/08820139.2010.508192     Document Type: Article

References (32)

1. Baggiolini, M., Dewald, B., Moser, B. (1994). Interleukin-8 and related chemotactic cytokines-CXC and CC chemokines. Adv. Immunol. 55:97-179.
2. Balasubramanian, A., Ganju, R.K., Groopman, J.E. (2003). Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes.J. Biol. Chem. 278:35755-35766.
3. Bosco, M.C., Gusella, G.L., Espinoza-Delgado, I., Longo, D.L., Varesio, L. (1994). Interferon-gamma upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism. Blood 83:537-542.
4. + active chronic hepatitis. Infez. Med. 16(2): 80-85.
5. El Serag, H.B. (2002). Hepatocellular carcinoma and hepatitis C in the United States. Hepatology 36:S74-S83.
6. Fang, S.H., Lai, M.Y., Hwang, L.H., Yang, P.M., Chen, P.J., Chiang, B.L., et al.. (2001). Ribavirin enhances interferon-γ levels in patients with chronic hepatitis C treated with interferon-α.J. Biomed. Sci. 8(6):484-491.
7. Feld, J.J., Lutchman, G.A., Heller, T., Hara, K., Pfeiffer, J.K., Leff, R.D., et al. (in press). Ribavirin improves early responses to peginterferon through enhanced interferon signaling.Gastroenterology, Accepted Manuscript, Available online 17 March 2010.
8. Francois, C., Duverlie, G., Rebouillat, D., Khorsi, H., Castelain, S., Blum, H.E., et al. (2000). Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis.J. Virol. 74:5587-5596.
9. Frank, C., Mostafa, M., Strickland, G.T., Lavanchy, D., Arthur, R., Madgder, L., et al. (2000). The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 355:887-891.
10. Girard, S., Shalhoub, P., Lescure, P., Sabile, A., Misek, D.E., Hanash, S., et al. (2002). An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295:272-283.
11. Guillou-Guillemette, H.L., Vallet, S., Gaudy-Graffin, C., Payan, C., Pivert, A., Goudeau, A., Lunel-Fabiani, F. (2007). Genetic diversity of the hepatitis C virus: Impact and issues in the antiviral therapy. World J. Gastroenterol. 13(17):2416-2426.
12. Halim, A.B., Garry, R.F., Srikanta, D., Berber, M.A. (1990). Effect of schistosomiasis and hepatitis on liver disease. Am.J. Trop. Med. Hyg. 60:915-920.
13. Heintges, T., Wands, J. (1997). Hepatitis C virus: Epidemiology and transmission. Hepatology 26:521-526.
14. Kamal, S., Madwar, M., Bianchi, L., Tawil, A., Fawzy, R., Peter, T. et al. (2000). Clinical, virological and histological features: Long-term follow-up in patients with chronic hepatitis C co-infected with S. mansoni. Liver 20:281-289.
15. Kamel, M.A., Gaffar, Y.A., Wasef, M.A., Wright, M., Clark, L.C., DeWolf Miller, F. (1992). High HCV prevalence in Egyptian blood donors. Lancet 340:427-429.
16. Kanai, K., Kako, M., Okamoto, H. (1992). HCV genotypes in chronic hepatitis C and response to interferon. Lancet 339:1543.
17. Kato, N., Yoshida, H., Kioko Ono-Nita, S., Kato, J., Goto, T., Otsuka, M. (2000). Activation of intracellular signaling by hepatitis B and C viruses: C viral core is the most potent signal inducer. Hepatology 32:405-412.
18. Khabar, K.S., Al Zoghaibi, F., Al Ahdal, M.N., Murayama, T., Dhalla, M., Mukaida, N. (1997). The alpha chemokine, interleukin-8, inhibits the antiviral action of interferon alpha.J. Exp. Med. 186:1077-1085.
19. Khabar, K.S., Al Zoghaibi, F., Murayama, T., Matsushima, K., Mukaida, N., Siddiqui, Y., et al. (1997). Interleukin-8 selectively enhances cytopathic effect (CPE) induced by positive-strand RNA viruses in the human WISH cell line. Biochem. Biophys. Res. Commun. 235:774-778.
20. Neuman MG, Sha K, Esguerra R, Zakhari S, Winkler RE, Hilzenrat N, Wyse J, Cooper CL, Seth D, Gorrell MD, Haber PS, McCaughan GW, Leo MA, Lieber CS, Voiculescu M, Buzatu E, Ionescu C, Dudas J, Saile B, and Ramadori G. (2008). Inflammation and repair in viral hepatitis C. Dig Dis Sci. 53(6):1468-1487.
21. Neuman, M.G., Benhamou, J.P., Martinot, M., Boyer, N., Shear, N.H., Malkiewicz, I. (1999). Predictors of sustained response to alpha interferon therapy in chronic hepatitis C. Clin. Biochem. 32:537-545.
22. Ohno, O., Mizokami, M., Wu, R.R., Saleh, M.G., Ohba, K., Orito, E., Mukaide, M., Williams, R., Lau, J.Y. (1997). New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a.J. Clin. Microbiol. 35(1):201-207.
23. Oliveira, I.C., Sciavolino, P.J., Lee, T.H., Vilcek, J. (1992). Down regulation of interleukin-8 gene expression in human fibroblasts: Unique mechanism of transcriptional inhibition by interferon. Proc. Natl. Acad. Sci. USA 89:9049-9053.
24. Oppenheim, J.J., Zachariae, C.O., Mukaida, N., Matsushima, K. (1991). Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu. Rev. Immunol, 9:617-648.
25. Paterson, M., Laxton, C.D., Thomas, H.C., Ackrill, A.M., Foster, G.R. (1999). Hepatitis C virus NS5A protein inhibits interferon antiviral activity, but the effects do not correlate with clinical response. Gastroenterology 117:1187-1197.
26. Polyak, S.J., Khalid, S., Khabar, A., Rezeiq, M., Gretch, D.R. (2001a). Elevated levels of interleukin-8 in serum are associated with hepatitis C virus infection and resistance to interferon therapy.J. Virol. 75(13): 6209-6211.
27. Polyak, S.J., Khabar, K.S., Paschal, D.M., Ezelle, H.J., Duverlie, G., Barber, G.N., et al. (2001b). Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.J. Virol. 75:6095-6106.
28. Sarrazin, C., Berg, T., Lee, J.H., Teuber, G., Dietrich, C.F., Roth, W.K., Zeuzem, S. (1999). Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b. Hepatology 30(6):1004-1013.
29. Schnyder-Candrian, S., Strieter, R.M., Kunkel, S.L., Walz, A. (1995). Interferon alpha and interferon-gamma down-regulate the production of interleukin-8 and ENA-78 in human monocytes.J. Leukoc. Biol. 57:929-935.
30. Strickland, T.G., Elhefni, H., Salman, T., Waked, I., Abdel-Hamid, M., Mikhail N. et al. (2002)/ Role of hepatitis C infection in chronic liver disease in Egypt. Am.J. Trop. Med. Hyg. 67:436-442.
31. Taub, D.D., Oppenheim, J.J. (1994). Chemokines, inflammation and the immune system. Ther. Immunol. 1:229-246.
32. Yasumoto, K., Okamoto, S., Mukaida, N., Murakami, S., Mai, M., Matsushima, K. (2002). Tumor necrosis factor alpha and interferon gamma An altered cellular response to interferon and up-regulation of interleukin-8 induced by the hepatitis C viral protein NS5A uncovered by microarray analysis. Virology 295:272-283.